Could a common breast cancer drug keep ovarian cancer at bay?
NCT ID NCT04111978
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial is testing whether adding letrozole (a hormone-blocking drug) to standard maintenance therapy can delay cancer recurrence in people with estrogen-receptor-positive ovarian cancer. About 540 participants who have completed initial surgery and chemotherapy will receive either letrozole or a placebo. The study aims to see if letrozole improves the time before the cancer comes back.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Letrozole (Femara)
- What this could lead to
- If it works, this could provide a new maintenance option to delay ovarian cancer recurrence after standard treatment.
- What could go wrong
- This is a Phase 3 trial, but it is still recruiting and results are not yet known. Letrozole may not improve progression-free survival compared to placebo, and side effects like bone thinning or hot flashes are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMO Wolfsburg / AMO MVZ GmbH
RECRUITINGWolfsburg, 38440, Germany
-
Agaplesion Diakonieklinikum Hamburg
RECRUITINGHamburg, 20259, Germany
-
Basel Claraspital AG
RECRUITINGBasel, 4002, Switzerland
-
Centre Hospitalier du Valais Romand
RECRUITINGSion, Valais, Switzerland
-
Charité - Universitätsmedizin Berlin Campus Virchow Klinikum
RECRUITINGBerlin, 13353, Germany
-
Donauisar Klinikum
RECRUITINGDeggendorf, 94469, Germany
-
Evangelische Kliniken Essen Mitte GmbH
RECRUITINGEssen, 45136, Germany
-
Evangelisches Krankenhaus Düsseldorf
RECRUITINGDüsseldorf, 40217, Germany
-
Frauenklinik Spital Grabs
RECRUITINGGrabs, 9472, Switzerland
-
Gynäkologisch-Onkologische Gemeinschaftspraxis Dres. med. C.Uleer/J.Y.Pourfard
RECRUITINGHildesheim, 31134, Germany
-
Helios Dr. Horst Schmidt Kliniken Wiesbaden
RECRUITINGWiesbaden, 65199, Germany
-
Helios Universitätsklinikum Wuppertal
RECRUITINGWuppertal, 42117, Germany
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, 1205, Switzerland
-
Kantonspital Graubünden (KSGR),
RECRUITINGChur, 7000, Switzerland
-
Kantonsspital Aarau AG
RECRUITINGAarau, Canton of Aargau, 5001, Switzerland
-
Kantonsspital Baden AG
RECRUITINGBaden, 5404, Switzerland
-
Kantonsspital Baselland
RECRUITINGLiestal, 4410, Switzerland
-
Kantonsspital Frauenfeld
RECRUITINGFrauenfeld, 8501, Switzerland
-
Kantonsspital Münsterlingen
RECRUITINGMünsterlingen, 8596, Switzerland
-
Kantonsspital St. Gallen
RECRUITINGSankt Gallen, 9007, Switzerland
-
Kantonsspital Winterthur
RECRUITINGWinterthur, 8401, Switzerland
-
Klinik Hietzing Wien
RECRUITINGVienna, 1130, Austria
-
Klinik für Onkologie und Hämatologie Hirslanden Zürich AG
RECRUITINGZurich, 8032, Switzerland
-
Klinikum Esslingen
RECRUITINGEsslingen am Neckar, 73730, Germany
-
Klinikum Konstanz
RECRUITINGKonstanz, 78464, Germany
-
Krankenhaus der Barmherzigen Brüder Graz
RECRUITINGGraz, 8020, Austria
-
Landeskrankenhaus Hochsteiermark Leoben
RECRUITINGLeoben, 8700, Austria
-
Leopoldina Krankenhaus der Stadt Schweinfurt
RECRUITINGSchweinfurt, 97422, Germany
-
Luzerner Kantonsspital
RECRUITINGLucerne, 6000, Switzerland
-
Medizinische Universität Graz
RECRUITINGGraz, 8036, Austria
-
Medizinische Universität Innsbruck
RECRUITINGInnsbruck, 6020, Austria
-
Medizinische Universität Wien
RECRUITINGVienna, 1090, Austria
-
Oncology Institute of Southern Switzerland (IOSI)-Ente Ospedaliero Cantonale (EOC)
RECRUITINGBellinzona, Canton Ticino, 6500, Switzerland
-
Ordensklinikum Linz Barmherzige Schwestern
RECRUITINGLinz, 4010, Austria
-
Praxis im Frauenzentrum Lindenhofspital
RECRUITINGBern, 3012, Switzerland
-
SL Klinikum Rosenheim
ACTIVE_NOT_RECRUITINGRosenheim, 83022, Germany
-
St. Elisabeth-Krankenhaus
RECRUITINGCologne, 50935, Germany
-
Stadtspital Triemli
RECRUITINGZurich, 8063, Switzerland
-
Studienzentrum Onkologie Ravensburg
RECRUITINGRavensburg, 88212, Germany
-
The University Medical Center Hamburg-Eppendorf
RECRUITINGHamburg, 20251, Germany
-
Tumorzentrum Hirslanden Klinik St. Anna
RECRUITINGLucerne, 6006, Switzerland
-
Unispital Zürich
RECRUITINGZurich, 8091, Switzerland
-
University Hospital Freiburg
RECRUITINGFreiburg im Breisgau, 79106, Germany
-
University Hospital Münster
RECRUITINGMünster, 48149, Germany
-
Universitätsklinik Ulm
RECRUITINGUlm, 89075, Germany
-
Universitätsklinik für Medizinische Onkologie, Inselspital
RECRUITINGBern, 3010, Switzerland
-
Universitätsklinikum Carl Gustav Carus Dresden
ACTIVE_NOT_RECRUITINGDresden, 01307, Germany
-
Universitätsklinikum Düsseldorf
RECRUITINGDüsseldorf, 40225, Germany
-
Universitätsklinikum Mannheim
RECRUITINGMannheim, 68167, Germany
-
Universitätsklinikum Salzburg
RECRUITINGSalzburg, 5020, Austria
-
Universitätsmedizin Mainz
RECRUITINGMainz, 55131, Germany
-
Universitätsspital Basel
RECRUITINGBasel, Canton of Basel-City, 4031, Switzerland
-
Universitätsspital Waadt/ CHUV
RECRUITINGLausanne, 1011, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can heated chemotherapy improve ovarian cancer outcomes?
- Can engineered immune cells target a common ovarian cancer protein?
- Artificial intelligence may predict ovarian cancer recurrence — a large study puts it to the test
- Experimental pill takes on Hard-to-Treat ovarian cancer
- Targeted drug hunts down cancer cells in advanced bladder cancer trial
- Radiation boost may Re-Sensitize ovarian cancer to PARP inhibitors